Initial catheter ablation achieved a lower risk of a composite primary endpoint event than anti-arrhythmic drug therapy in patients who survived a heart attack. Rapid Initiation of SGLT2 Inhibitors Improves Cost-Effectiveness of Therapy, with Ankeet Bhatt, MD, MBA ...
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for Identifying Patients at Risk for Sudden Cardiac Death: A Scientific Statement From the American Heart Association Council on Clinical Cardiology ...
American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society Scientific Statement on Noninvasive Risk Stratification Techniques for ... JJ Goldberger,ME Cain,SH Hohnloser,... - 《Journal of the American College of Cardiology》 ...
TheJournal of the American Heart Associationhas concurred with a previous report by theHeart Rhythm Journalwhich saidclose contact with aniPhone 12affected certain implantable cardiac devices. As with that report, the American Heart Association says the effect are solely when...
370. A 78-year-old man who has ischemic heart failure, New York Heart Association (NYHA) functional class IV, and severe chronic obstructive pulmonary disease is admitted to the ICU for cardiac decompensation. This is his third admission in the past 2 months, and he is now having difficulty...
In March 2024, the label for bempedoic acid was expanded to reduce cardiovascular risk and expand the low-density lipoprotein-C (LDL-C) lowering in both primary and secondary prevention patients. Empagliflozin Shows 10% Relative Risk Reduction in Time to First Hospitalization Due to Heart Failure ...
the generation time of fetal and ma- bilical cord blood lymphocytesfailed to show a response ternal cells in culture; 4. the length of survival of as assessed by mitotic rate. It is suggested that the fetal cells in the maternal circulation; 5. the relative transfer of fetal lymphocytes to...
CAMZYOS (mavacamten) is the first and only cardiac myosin inhibitor approved in the U.S., reports Bristol Myers Squibb, which further notes: CAMZYOS is indicated for the treatment of adults with symptomatic New York Heart Association (NYHA) class II-III obstructive hypertrophic cardiomyo...
b. ATDs: Patients with high likelihood of remission (pa- tients, especially women, with mild disease, small goi- ters, and negative or low-titer TRAb); pregnancy; the elderly or others with comorbidities increasing surgi- cal risk or with limited life expectancy; individuals in nursing homes...
期刊名称:《Circulation: An Official Journal of the American Heart Association》 | 2015年第10期 39.Cardiac Arrest in Pregnancy A Scientific Statement From the American Heart Association 机译:妊娠期心脏骤停美国心脏协会的科学声明 作者:Jeejeebhoy Farida M.;Zelop Carolyn M.;Lipman Steve;Carvalho Brenda...